<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03632460</url>
  </required_header>
  <id_info>
    <org_study_id>UHDubrava777</org_study_id>
    <nct_id>NCT03632460</nct_id>
  </id_info>
  <brief_title>Dexmedetomidine and Dexamethasone as an Adjuvant to Ropivacaine in Thoracic Surgery</brief_title>
  <official_title>Comparison of Epidural Dexmedetomidine and Dexamethasone as an Adjuvant to Ropivacaine on Postoperative Pain Level, Analgesic Consumption and Oxidative Stress in Thoracic Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Dubrava</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Dubrava</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to investigate the effect of preoperative epidural dexmedetomidine
      compared to dexamethasone on postoperative pain control, analgesic consumption and oxydative
      stress response in patients undergoing thoracic surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The aim of the study is to investigate the effect of preoperative epidural dexmedetomidine
      compared to dexamethasone on postoperative pain control, analgesic consumption and oxydative
      stress response in patients undergoing thoracic surgery.

      Investigation will include patients between 30-70 years undergoing thoracic surgery due to
      malignant process of lung or oesophagus.

      Patients are divided in two groups: epidural administration of 0.375% ropivacaine with 1
      mcg/kg dexmedetomidine (group 1) and epidural administration of 0.375% ropivacaine with 8 mg
      dexamethasone.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2018</start_date>
  <completion_date type="Anticipated">May 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in postoperative pain level using visual analogue scale</measure>
    <time_frame>Before operation, 1 hour, 2 hour, 6 hour and 24 hour after operation</time_frame>
    <description>Change in baseline postoperative pain level measured before operation, and then at 1h, 2h, 6h and 24h after operation using visual analogue scale. Visual analogue scale is numerical scale in range from 1-10, assessing pain level. Minimum score is 1, which represents- no pain to maximum score 10 which represents- the worst pain ever experienced.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>24 hour</time_frame>
    <description>analgesic consumption in time interval</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxydative stress level</measure>
    <time_frame>24 hour</time_frame>
    <description>malonyldialdehyde, glutathion, catalase</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Pain, Postoperative</condition>
  <condition>Oxidative Stress</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 mcg/kg dexmedetomidine added to 8 ml 0.375% ropivacaine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>8 mg dexamethasone added to 8 ml 0,375% ropivacaine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine Injection [Precedex]</intervention_name>
    <description>epidural administration of dexmedetomidine added to ropivacaine</description>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_label>Dexmedetomidine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients undergoing thoracic surgery due to malignant process of lung or oesophagus
             ASA (American Society of Anesthesiologists) status I-III

        Exclusion Criteria:

          -  neurological or psychiatric disease

          -  corticosteroid therapy

          -  anamnesis of myocardial infarct within last 6 months

          -  severe aortic stenosis

          -  kidney insufficiency

          -  liver insufficiency

          -  allergy

          -  coagulation disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jasminka Persec, Assit Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Dubrava</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrej Sribar, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University Hospital Dubrava</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jasminka Persec, Assist Prof</last_name>
    <phone>+385 1 2902433</phone>
    <phone_ext>+38512902440</phone_ext>
    <email>jasminka@kbd.hr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrej Sribar, MD PhD</last_name>
    <phone>+385 1 2902440</phone>
    <phone_ext>+38512902440</phone_ext>
    <email>andrej.sribar@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Jasminka Persec</name>
      <address>
        <city>Zagreb</city>
        <zip>10000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <contact>
      <last_name>Andrej Sribar, MD</last_name>
      <phone>+38512902433</phone>
      <phone_ext>+38512902433</phone_ext>
      <email>jasminka@kbd.hr</email>
    </contact>
    <contact_backup>
      <last_name>Jasminka Persec</last_name>
      <phone>+38512902433</phone>
      <phone_ext>+38512902433</phone_ext>
      <email>jasminka@kbd.hr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <results_reference>
    <citation>Kim NY, Kwon TD, Bai SJ, Noh SH, Hong JH, Lee H, Lee KY. Effects of dexmedetomidine in combination with fentanyl-based intravenous patient-controlled analgesia on pain attenuation after open gastrectomy in comparison with conventional thoracic epidural and fentanyl-based intravenous patient-controlled analgesia. Int J Med Sci. 2017 Aug 18;14(10):951-960. doi: 10.7150/ijms.20347. eCollection 2017.</citation>
    <PMID>28924366</PMID>
  </results_reference>
  <results_reference>
    <citation>Hong JM, Kim KH, Lee HJ, Kwon JY, Kim HK, Kim HJ, Cho AR, Do WS, Kim HS. Epidural Dexamethasone Influences Postoperative Analgesia after Major Abdominal Surgery. Pain Physician. 2017 May;20(4):261-269.</citation>
    <PMID>28535549</PMID>
  </results_reference>
  <results_reference>
    <citation>Gallego-Ligorit L, Vives M, Vallés-Torres J, Sanjuán-Villarreal TA, Pajares A, Iglesias M. Use of Dexmedetomidine in Cardiothoracic and Vascular Anesthesia. J Cardiothorac Vasc Anesth. 2018 Jun;32(3):1426-1438. doi: 10.1053/j.jvca.2017.11.044. Epub 2017 Dec 2. Review.</citation>
    <PMID>29325842</PMID>
  </results_reference>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 8, 2018</study_first_submitted>
  <study_first_submitted_qc>August 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 15, 2018</study_first_posted>
  <last_update_submitted>August 14, 2018</last_update_submitted>
  <last_update_submitted_qc>August 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Dubrava</investigator_affiliation>
    <investigator_full_name>Jasminka Persec, MD, PhD</investigator_full_name>
    <investigator_title>Assist Prof MD PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

